Literature DB >> 16061659

Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.

Xuesong Ouyang1, Theodore L DeWeese, William G Nelson, Cory Abate-Shen.   

Abstract

Despite the significance of oxidative damage for carcinogenesis, the molecular mechanisms that lead to increased susceptibility of tissues to oxidative stress are not well-understood. We now report a link between loss of protection against oxidative damage and loss-of-function of Nkx3.1, a homeobox gene that is known to be required for prostatic epithelial differentiation and suppression of prostate cancer. Using gene expression profiling, we find that Nkx3.1 mutant mice display deregulated expression of several antioxidant and prooxidant enzymes, including glutathione peroxidase 2 and 3 (GPx2 and GPx3), peroxiredoxin 6 (Prdx6), and sulfyhydryl oxidase Q6 (Qscn6). Moreover, the formation of prostatic intraepithelial neoplasia in these mutant mice is associated with increased oxidative damage of DNA, as evident by increased levels of 8-hydroxy-2'-deoxyguanosine. We further show that progression to prostate adenocarcinoma, as occurs in compound mutant mice lacking Nkx3.1 as well as the Pten tumor suppressor, is correlated with a further deregulation of antioxidants, including superoxide dismutase enzymes, and more profound accumulations of oxidative damage to DNA and protein, the latter manifested by increased levels of 4-hydroxynonenal. We propose that the essential role of Nkx3.1 in maintaining the terminally differentiated state of the prostate epithelium provides protection against oxidative damage and, thereby, suppression of prostate cancer. Thus, our findings provide a molecular link between a gene whose inactivation is known to be involved in prostate carcinogenesis, namely Nkx3.1, and oxidative damage of the prostatic epithelium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061659     DOI: 10.1158/0008-5472.CAN-05-1948

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

1.  Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate.

Authors:  Sachin S Bhusari; Joseph R Dobosy; Vivian Fu; Nima Almassi; Terry Oberley; David F Jarrard
Journal:  Epigenetics       Date:  2010-07-01       Impact factor: 4.528

2.  A molecular signature predictive of indolent prostate cancer.

Authors:  Shazia Irshad; Mukesh Bansal; Mireia Castillo-Martin; Tian Zheng; Alvaro Aytes; Sven Wenske; Clémentine Le Magnen; Paolo Guarnieri; Pavel Sumazin; Mitchell C Benson; Michael M Shen; Andrea Califano; Cory Abate-Shen
Journal:  Sci Transl Med       Date:  2013-09-11       Impact factor: 17.956

3.  Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.

Authors:  Anamika Basu; Hiya Banerjee; Heather Rojas; Shannalee R Martinez; Sourav Roy; Zhenyu Jia; Michael B Lilly; Marino De León; Carlos A Casiano
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

4.  Differential response of normal (PrEC) and cancerous human prostate cells (PC-3) to phenethyl isothiocyanate-mediated changes in expression of antioxidant defense genes.

Authors:  Anna A Powolny; Shivendra V Singh
Journal:  Pharm Res       Date:  2010-09-25       Impact factor: 4.200

Review 5.  Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets.

Authors:  Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

6.  A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes.

Authors:  Debika Biswal Shinohara; Ajay M Vaghasia; Shu-Han Yu; Tim N Mak; Holger Brüggemann; William G Nelson; Angelo M De Marzo; Srinivasan Yegnasubramanian; Karen S Sfanos
Journal:  Prostate       Date:  2013-02-06       Impact factor: 4.104

7.  Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.

Authors:  Lizheng Guo; Diansheng Zhong; Stephen Lau; Xiuju Liu; Xue-Yuan Dong; Xiaodong Sun; Vincent W Yang; Paula M Vertino; Carlos S Moreno; Vijay Varma; Jin-Tang Dong; Wei Zhou
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

8.  Association of TGIFLX/Y mRNA expression with prostate cancer.

Authors:  Z Ousati Ashtiani; M Ayati; M H Modarresi; R Raoofian; B Sabah Goulian; W K Greene; M Heidari
Journal:  Med Oncol       Date:  2008-07-29       Impact factor: 3.064

9.  QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.

Authors:  Gøril Knutsvik; Karin Collett; Jarle Arnes; Lars A Akslen; Ingunn M Stefansson
Journal:  Mod Pathol       Date:  2016-08-26       Impact factor: 7.842

10.  Disulfide bond generation in mammalian blood serum: detection and purification of quiescin-sulfhydryl oxidase.

Authors:  Benjamin A Israel; Lingxi Jiang; Shawn A Gannon; Colin Thorpe
Journal:  Free Radic Biol Med       Date:  2014-01-25       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.